Endo Investors Ink $63M Deal In Generics Stock Inflation Suit
Endo International and a class of investors told a Pennsylvania federal court Friday that they reached a $63.4 million settlement to resolve claims Endo inflated its stock price by hiking its...To view the full article, register now.
Already a subscriber? Click here to view full article